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Background: Sarcopenia is an important public health problem that affects mainly elders, and has negative
consequences, such as disability and even death. Due to the lack of studies evaluating sarcopenia in elderly persons
hospitalized in Brazil, the aim of the present study was to describe the frequency of sarcopenia and associated
factors among elders in a hospital in the city of Salvador - Brazil.
Methods: This cross-sectional study included 110 hospitalized elderly patients in a multi-specialty hospital in Salvador-BA,
Brazil. Inclusion criteria: were elders aged ≥60 years between the first and fifth day of hospitalization; who were able to
walk without external assistance; with medical permission to walk, and who did not take vasoactive and inotropic drugs.
The diagnosis of sarcopenia was determined by combining the reduction in skeletal muscle mass with muscle weakness
(women, <20 kg; men, <30 kg) and/or poor physical performance (gait speed ≤0.8 m/s). To obtain reduced skeletal
muscle mass, the skeletal muscle mass index ≤6.37 kg/m2 for women and ≤8.90 kg/m2 for men was used. Cognitive
function, Charlson index, admission profile (clinical and surgical), smoking, falls suffered in the last year and physical
inactivity prior to admission were also evaluated. The frequency of sarcopenia was described in percentages with their
respective confidence intervals and logistic regression was performed for multivariate analysis of factors associated with
sarcopenia.
Results: Among the 110 patients included, the frequency of sarcopenia was 21.8%, with 10.0% being of the severe type.
There was a predominance of clinical profile (59.1%), such as heart disease (20.0%), pneumonia (13.6%) and skin infections
(9.1%), with a Charlson index of 5.4 ± 1.8. The factors associated with sarcopenia were age (OR = 1.14; 95% CI = 1.06 to
1.23), clinical profile on admission (OR = 5.15; 95% CI = 1.16–22.9) and smoking (OR = 7.8; 95% CI = 1.53–39.9).
Conclusions: The frequency of sarcopenia in elderly hospitalized patients was high (1 in 5 elderly) and anthropometric
equation can be a viable and inexpensive alternative to screening and programming intervention in this population.
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The reduction in muscle mass that occurs with aging
was initially described by Rosenberg in 1989 [1]. In
1998, Baumgartner and colleagues developed a practical
method to assess sarcopenia, using the muscle mass
index (MMI). These authors suggested that the accepted
values for sarcopenia were two standard deviations
below the standard values for a specific population as a
function of gender and age [2]. However, the current* Correspondence: brunopmartinez@hotmail.com
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unless otherwise stated.definition of sarcopenia, established by the European
Working Group on Sarcopenia in Older People (EWG-
SOP), includes a reduction in strength and/or physical
performance, in addition to a reduction in skeletal
muscle mass [3].
Older people are highly susceptible to sarcopenia,
which maybe be associated with increased muscle weak-
ness [4], falls/fractures [5], limitations in activities [6,7]
and increased risk of death [8-10]. However, the weak-
ness may be related to other causes, such as neural and
muscle factors, and not the reduction in mass only
[3,11]. Previous studies have reported that the global
frequency of sarcopenia ranges from 3.0% to 36.1%l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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This wide variation can be explained by the different
methods and diagnostic criteria used. The use of an-
thropometric measures is a simple and inexpensive
methods to assess sarcopenia, but with lower accuracy.
Nonetheless, Lee et al. [17] developed predictive equa-
tions for muscle mass based on anthropometric mea-
surements, and verified that these measurements were
strongly correlated with data obtained by the use of
magnetic resonance imaging [17] and dual-energy X-ray
absorptiometry (DEXA) [14].
Most studies about sarcopenia included community-
dwelling elderly and few studies have reported fre-
quency of the disease among the hospitalized elderly.
Hospitalization may have negative consequences such
cognitive impairment, physical disability, prolonged
hospitalization, social isolation and decreased quality of
life [18]. Therefore, early identification of sarcopenia is
essential, particularly in the hospital setting, considering
that some risk factors are present. Due to the lack of
studies evaluating sarcopenia in elderly hospitalized pa-
tients in Brazil, the aim of the present study was to de-
scribe the frequency of sarcopenia and associated
factors among elderly patients in a hospital in the city of
Salvador - Brazil.
Methods
This study included 110 elderly patients admitted to the
City hospital, a multi-specialty hospital providing care for
patients from both the public and supplementary health
systems, located in the city of Salvador, Bahia, Brazil. The
study was conducted in the period from August 2013 to
January 2014. The inclusion criteria were hospitalized in-
dividuals aged ≥60 years, examined in the time between
the first and fifth day of hospitalization, who were not
under treatment with vasoactive and inotropic drugs, able
to walk without external assistance or auxiliary devices,
who had medical permission to walk, who had no pain,
dyspnea or cardiopulmonary change that prevented them
from performing physical activity.
The primary variables were anthropometric measure-
ments, handgrip strength, gait speed, cognitive function, his-
tory of falls in the last year and smoking status. The
secondary variables obtained were medical admission diag-
nosis, admission profile (clinical or surgical), length of stay
hospital during data collection, and the Charlson index to
assess comorbidities. On a daily basis, the researchers
checked the electronic medical record system to find pa-
tients who met the criteria for inclusion in the study. The
Research Ethics Committee of the Bahia School of Medicine
and Public Health approved the project under Protocol
Number 336.469 / 2013. After being duly informed about
the research, all patients signed a term of free and informed
consent to participate in the study.Measurement
For the diagnosis of sarcopenia, muscle mass, handgrip
strength and physical performance were measured. Skel-
etal muscle mass was estimated (SMM) using the Lee
equation [17] for patients with BMI <30: (0.244 * body
weight) + (7.8 * height) + (6.6 * gender) − (0.098 * age)
+ (race − 3.3); with body weight in kilograms and height
in meters. The value 0 must be used for women, 1 for
men, then 0 for whites, 1.4 for blacks and −1.2 for
Asians [17]. A recent Brazilian study demonstrated
strong agreement between DEXA and this predictive
equation for muscle mass (k = 0.74; p <0.001), with a
high specificity (89%) and sensitivity (86%) [14]. For eld-
erly patients with BMI ≥30 kg/m2, the specific an-
thropometric equation [17]: {height * (0.007444 * CAG2
+ 0.00088 * CTG2 + 0.00441 * CCG2) + 2.4 * gender –
0.048 * age + race + 7.8} was used.
The skinfold thickness measurements (S) in the arm,
thigh and medial part of the calf were performed by
trained evaluators; and the circumferences of the limbs
(Climb) in the mid upper arm, mid thigh and mid calf
were also measured to the nearest 1 mm, according to
anthropometric standardization [19]. We used the Lange
caliper (USA) to measure the skinfold thickness. Three
measurements were performed and the mean of the
measurements was obtained for analysis. To remove the
fat component, the corrected value of the circumference
(Cm: Climb - π.S) was obtained [17]. Subsequently, the
SSM was divided by height squared to obtain the skeletal
muscle mass index (MMI). The criteria used to assess
the reduction in skeletal muscle mass were values
≤6.37 kg/m2 for female patients and ≤8.90 kg/m2 for
male patients, which are equivalent to 20% of lowest
percentile distribution reported by Alexandre et al. [16],
according to the studies by Newman et al. [20] and
Delmonico et al. [21].
Body mass index (BMI) was also calculated by dividing
the weight (in kg) by the square of height (in m). The
values established by the Lipschitz et al. [22] recommen-
dation, which allows for changes in body composition
owing to aging, were used to classify the following: under-
weight, BMI <22 kg/m2; normal weight, BMI between 22
and 27 kg/m2 and excess weight, BMI >27 kg/m2 [22].
To assess handgrip strength, the participants were
asked to sit on a chair with elbows positioned at a 90°
angle and exert maximum force, using a Saehan hydraulic
dynamometer (Saehan Corporation, 973, Yangdeok-Dong,
Masan 630–728, Korea). This dynamometer presented high
reliability in comparison with the gold standard, which is
the Jamar dynamometer [23]. This measurement was per-
formed three times, with a 1-min rest interval between mea-
surements, and the highest values were considered. For
assessing muscle weakness, values <20 kg and <30 kg were
considered for female and males, respectively [24].
Table 1 Descriptive characteristics of the sample of 110
hospitalized elderly patients included in the study,
categorized in elderly with sarcopenia (sarcopenia and
severe sarcopenia) and without sarcopenia
Sarcopenia No sarcopenia
Variables % (n) Mean/SD % (n) Mean/SD
Age 78.9 ± 9.5 68.8 ± 6.8
60–69 years 16.7 (4) 62.8 (54)
70–79 years 33.3 (8) 27.9 (24)
≥80 years 50.0 (12) 9.3 (8)
BMI 21.5 ± 2.4 26.5 ± 4.6
Underweight 54.2 (13) 10.5 (9)
Normal weight 445.8 (11) 53.5 (46)
Excess weight 0.0 (0) 36.0 (31)
Gender
Male 50.0 (12) 60.5 (52)
Female 50.0 (12) 39.5 (34)
Admission profile
Clinical 87.5 (21) 51.2 (44)
Surgical 12.5 (3) 48.8 (42)
MMSE 20.4 ± 5.7 24.7 ± 4.4
Charlson index 6.3 ± 1.9 5.2 ± 1.7
≤4 25.0 (6) 39.5 (34)
≥5 75.0 (18) 60.5 (52)
Length of stay
(days) 2.8 ± 1.7 2.7 ± 1.6
1–3 62.5 (15) 65.1 (56)
≥3 37.5 (9) 34.9 (30)
Smoking
Absent 70.8 (17) 93.0 (80)
Present 29.2 (7) 7.0 (6)
Physical activity
<twice a week
No 17.4 (4) 41.6 (32)
Yes 82.6 (19) 58.4 (45)
Falls in the last year
Absent 62.5 (15) 77.9 (67)
Present 37.5 (9) 22.1 (19)
SMM (kg) 17.5 ± 4.1 23.1 ± 5.1
MMI (kg / m2) 6.8 ± 1.6 8.8 ± 1.7
Handgrip (kg) 18.9 ± 6.7 30.5 ± 8.4
Gait speed (m / s) 0.95 ± 0.4 1.36 ± 0.41
BMI = Body mass index; MMSE =Mini mental state exam; SMM = Skeletal
muscle mass; MMI = Muscle mass index.
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was the 6-m gait speed test. For this purpose, partici-
pants were asked to walk a distance of 10 m on a flat
surface, in a straight line, as fast as they could, and the
time taken to walk the middle 6 m was measured. The
highest values were considered, and values ≤0.8 m/s in-
dicated poor physical performance [25].
Cognitive function was assessed using the mini-mental
state examination (MMSE), which quantifies various do-
mains of cognition, with a score ranging from 0 to 30 [26].
The report of low physical activity pre-admission was
graded positive for elderly people who were inactive or who
performed physical activity <2 times a week [27]. To evalu-
ate the severity of the patients’ comorbidities, data were col-
lected by means of the Charlson comorbidity index within
the first 24 hours of admission [28]. The elderly who re-
ported having smoked at least one cigarette per day in the
last month were considered smokers [29]. Self-reports of
falls in the past year were also evaluated.
Statistical analysis
The numerical variables were expressed as means and
standard deviations, and the categorical data were
expressed in percentages with their respective confi-
dence intervals. The association between sarcopenia and
length of stay at the time of data collection, and the
Charlson index were analyzed using the chi-square test
(Length of hospital stay during data collection: ≤3 days
and 3–5 days, Charlson index: ≤4 and ≥5). The inter-
group comparisons of the variables age, BMI, Charlson
index, cognitive function, handgrip strength, and gait
speed were performed using the Student’s t-test for inde-
pendent variables. Multivariate analysis of factors associ-
ated with sarcopenia was performed by the logistic
regression (backward method), which included the six
most significant variables: age, cognitive function, admis-
sion profile (clinical or surgical), smoking, age ≥80 years
and reports of physical inactivity pre-hospitalization (less
than 2x per week). One hundred patients were evalu-
ated, considering an estimated error of 7%, a significance
level of 5%, and an expected rate of sarcopenia of 15%,
based on previous studies [15,16,30]. The analyses were
performed using the SPSS software version 14.0, and p-
values of <0.05 were considered significant.
Results
Descriptive data of 110 elderly patients evaluated in this
study are described in Table 1 and Figure 1. According to
the definitions of sarcopenia related by the European
Working Group on Sarcopenia in Older People, the preva-
lence of sarcopenia was 21.8% (95% CI = 14.5–30.7). Of
the 24 older people with sarcopenia, 41.7% had severe sar-
copenia. Ten elderly patients (9.1%) had pre-sarcopenia,
since they had only a reduction in skeletal muscle mass.In this study, there was a predominance of clinical pa-
tients (59.1%), and the most common reasons for admission
were abdominal surgeries (34.5%), heart disease (20.0%),
Figure 1 Algorithm of 110 elderly patients evaluated by the study according European working group on Sarcopenia in older people.
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hospital stay during data collection was 2.7 ± 1.6 days and
64.5% of measurements were obtained between the first
and third days of admission. There was no difference in the
occurrence of sarcopenia among the different length of stay
during data collection. Sixty-four percent of participants
reported practicing <2 days of physical activity per week
before hospital admission. With regard to BMI, normal
weight (51.8%) predominated, followed excess weight
(28.2%) with 20.0% being classified as underweight.Table 2 Univariate and multivariate analysis of factors associ
hospitalized elderly
Univariate an
Variables OR (CI 95%)
Age 1.16 (1.09–1.24
Age (60–69 years) 0.12 (0.04–0.38
Age (70–79 years) 1.29 (0.49–3.4)
Age (≥80 years) 9.8 (3.3–28.8)
Gender (Male) 0.7 (0.3–1.6)
Admission profile (Clinical) 6.7 (1.9–24.1)
MMSE 0.87 (0.77–0.93
Charlson index 1.4 (1.07–1.82)
Charlson index (≥5) 2.3 (0.8–6.9)
Length of stay (days) 1.1 (0.4–2.9)
Smoking (Present) 5.5 (1.6–18.4)
Falls in the last year (Present) 2.1 (0.8–5.6)
Physical activity prior (less than 2x per week) 3.4 (1.1–10.9)In the intergroup comparison, elderly patients with
sarcopenia exhibited a lower level of cognitive function
than the group without sarcopenia, as well as higher
values for age and Charlson index (Table 2). In the com-
parison of categorical variables the highest frequencies
of sarcopenia occurred in the clinical profile on admis-
sion, older age groups, smokers, those with worse cogni-
tive function and in those who reported low levels of
physical activity pre-hospitalization (Table 2). After
multivariate analysis, only age, admission clinical profileated with sarcopenia in the sample of 110
alysis Multivariate analysis
P-value OR (CI 95%) P-value










0.007 7.8 (1.5–39.9) 0.014
0.13
0.034
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The frequency of sarcopenia among hospitalized elderly
patients was 21.8% and higher than the results of a recent
study involving older people with acute disease (10%) [31].
The main explanation for the lower frequency in the re-
ported study is the different method used to determine
muscle mass, which consisted of calculating the arm cir-
cumference and triceps skinfold, differently from the
present study, in which the anthropometric equation was
used. In addition, the previous study did not assess phys-
ical performance for diagnosing sarcopenia, which may
have underestimated its occurrence.
In a recent study conducted in Brazil, Alexander et al.
[16] also adopted the Lee anthropometric equation to
assess muscle mass, and reported a prevalence of 15.4%
in community-dwelling older people, which was slightly
lower than the present study results. Although these
were not hospitalized elderly, they had a high frequency
of comorbidities, including hypertension (61%), osteo-
arthritis (32.4%), and heart disease (20.8%).
Similar to our study, Yamada et al. [32] reported 21.8%
prevalence of sarcopenia in community-dwelling older
people in Japan, based on the use of electrical bioimpe-
dance measurement of skeletal muscle mass. This rate
was higher than that of older people in UK (7.8%) [15]
and of those aged >80 years in the study of Belfrail
(12.5%) [33]. Differently from the study involving British
older people, which primarily used anthropometric skin-
fold thickness measurements for the definition of de-
creased muscle mass [15], whereas we adopted the Lee
anthropometric equation in our study. Despite the lower
accuracy of anthropometric measurements to predict
muscle mass in comparison with the gold standard
[14-16], recent studies have used anthropometry because
of its low cost and operational simplicity for the early
identification of sarcopenia, which may be considered a
valid option in daily care for screening patients in need
of specific interventions.
Despite its negative outcome, such as disability [7] and
increased mortality [10], sarcopenia remains understudied,
and limited knowledge is available about hospitalized older
people. Quantifying the prevalence of sarcopenia is essential
to warn healthcare professionals about this disease and its
negative consequences, including death [31,10]. Further-
more, hospitalization usually is associated with diseases and
comorbidities, which can trigger sarcopenia through the in-
crease in inflammatory response, physical inactivity and
malnutrition [34,35]. The elderly patients included in the
study were not submitted to specific strength or balancetraining before the measurements taken for the present
study.
Factors associated with sarcopenia
The higher frequency of sarcopenia in older age groups
found in this study is similar to the findings of previous
studies [2,15,16] that have reported a rise in frequency,
mainly among those in age groups older than 80 years.
A justification for this is the possible reduction in motor
neurons, which was demonstrated by McNeil et al. [36]
who observed a reduction of almost 50% in motor neu-
rons between 60–80 years of age. In the present study
each year of age from 60 years onwards, there was a 14%
increase in the odds ratio of the elderly having sarcope-
nia. In this study, half of the elderly patients with sarco-
penia were older than 80 years, but after multivariate
analysis this was not statistically significant, probably
due to the small sample size.
In addition to the predominance of patients with clinical
profile on admission in the sample, 87.5% older people
with sarcopenia exhibited the clinical profile, and the odds
ratio for patients with clinical profile to have sarcopenia
was 5.15 compared with patients with surgical profile,
after multivariate analysis. One explanation for this find-
ing is that most of the surgeries were of the elective ab-
dominal type (34.5%) and patients with a clinical profile
were older and had a longer stay in hospital during data
collection. This may have influenced the low frequency of
cases of sarcopenia in surgical patients, considering the
lack of significant differences in the Charlson index be-
tween the surgical and medical patients (5.1 ± 1.7 vs. 5.7 ±
1.9, respectively; p-value = 0.35). Another aspect is that pa-
tients with a clinical profile had a predominance of heart
disease, pneumonia and infections, suggesting the influ-
ence of triggering inflammatory mechanism of protein
degradation, malnutrition and consequent sarcopenia
[34,35]. Another factor associated with sarcopenia was
smoking, which in this study showed an odds ratio of 7.8.
This can be explained by the possible increase in the in-
flammatory response triggered by smoking [37], and other
causes such as impairment of energy supply and oxygen
to the muscle and metabolic pathways, promoted by re-
duced blood flow [16,38,39].
In the intergroup comparison of sarcopenia, BMI values
were lower in subjects with sarcopenia, however the aver-
age value was classified as normal and similar to those of
recent studies [15,33,35] and to the Brazilian study [16].
Only 20.0% of the 110 older patients studied were classi-
fied as underweight, and this result differs from that of an-
other study involving hospitalized older people, in which
62% of the participants were underweight [31].
With regard to cognitive functions, no significant associ-
ation was found after multivariate analysis, corroborating
the study of Kan et al. [40] who also found no association
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gitudinal studies with larger sample sizes are warranted to
better assess the correlations, causal effects, and the long-
term effects of sarcopenia.
The study had some limitations, such as the cross-
sectional nature of the study, which prevents a cause-
effect relationship in some relations. Nonetheless, the use
of high-precision instruments would have prevented the
development of the present study, considering the oper-
ational and financial issues involved. The frequency of sar-
copenia may also have been underestimated, because
older people with more severe and acute conditions and
those with inability to perform physical tests and/or who
used an auxiliary device or external assistance were ex-
cluded. In addition, the anthropometric equation applied
in the twelve elderly with BMI ≥30 led to a higher risk of
bias in the measurement of skeletal muscle mass, which
cannot indicate sarcopenic obesity in the elderly. Another
limitation was the failure to use a special tool to evaluate
the nutritional aspect, in addition to BMI.
Conclusions
The frequency of sarcopenia among hospitalized elderly pa-
tients was high (1 in 5 elderly), which demonstrates the need
for further research into its causes and consequences in hos-
pitalized patients. The use of anthropometric measurements
may be practical and feasible for the early detection of sarco-
penia and should be used in the hospital setting because of
the negative outcomes of this condition, and the possibility
of managing certain modifiable factors. The factors associ-
ated with sarcopenia in elderly hospitalized patients were
age, clinical profile on admission and smoking.
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